Results 321 to 330 of about 133,417 (336)

Chemoradiotherapy for unresectable pancreatic cancer

International Journal of Clinical Oncology, 2008
Treatment options for unresectable pancreatic cancer, including concurrent chemoradiotherapy, chemotherapy alone, and chemotherapy followed by chemoradiotherapy, are largely ineffective and result in a median survival of approximately 10-12 months. Although quality data on the benefit of radiotherapy in unresectable pancreatic cancer are lacking, it ...
Edgar Ben-Josef, Theodore S. Lawrence
openaire   +3 more sources

The use of chemoradiotherapy in oesophageal cancer

European Journal of Cancer, 2002
The results of treatment for oesophageal carcinoma remain poor and few patients are curable by surgery alone. The use of chemoradiotherapy (CRT) given as a definitive treatment or in combination with surgery may improve locoregional control and survival, when compared with radiotherapy or surgery alone.
openaire   +3 more sources

Hip complications following chemoradiotherapy

Clinical Oncology, 1995
Chemoradiotherapy protocols are a recent development in the management of tumours where preservation of organ function is important. It is now recognized that such combined treatment may produce adverse effects below the accepted dose thresholds for either modality.
D.J. Sebag Montefiore, P.J. Jenkins, S.J. Arnott   +2 more
openaire   +3 more sources

Postoperative chemoradiotherapy for gallbladder cancer

Strahlentherapie und Onkologie, 2012
The goal of this work was to analyze the outcome of adjuvant chemoradiotherapy for patients with gallbladder cancer who underwent surgical resection and to identify the prognostic factors for these patients.Between August 1989 and November 2006, 47 patients with gallbladder cancer underwent surgical resection followed by adjuvant radiotherapy.
Kyu-Pyo Kim, Do Youn Oh, Yung-Jue Bang, Sun Whe Kim, Eui Kyu Chie, Eui Kyu Chie, Seock-Ah Im, Sae-Won Han, Tae-You Kim, Sung Whan Ha, Sung Whan Ha, Jin-Young Jang   +11 more
openaire   +3 more sources

Radiotherapy and chemoradiotherapy for carcinoma of the vulva [PDF]

Best Practice & Research Clinical Obstetrics & Gynaecology, 2003
Radiotherapy may be used in the treatment of vulval cancer as an alternative to surgery in unfit patients, as an adjuvant to surgery in patients with poor prognosis tumours and for the treatment of inoperable, recurrent and metastatic disease. High-energy X-rays, electrons and both superficial mould and interstitial brachytherapy may be integrated in ...
openaire   +2 more sources

Chemoradiotherapy for Cervical Cancer in 2010

Current Oncology Reports, 2010
The introduction of concurrent chemotherapy and radiotherapy for the definitive treatment of cervical cancer constituted a major advance in the management of cervical cancer, resulting in a significant improvement in local control, progression-free survival, and overall survival.
Patricia J. Eifel, Ann H. Klopp
openaire   +3 more sources

Stage III: Definitive Chemoradiotherapy

2009
Concurrent chemoradiotherapy is presently the standard treatment for stage III inoperable non-small cell lung cancer. Within this treatment framework, conventionally fractionated radiotherapy to a total dose of 60-66 Gy has proven effective. The chemotherapy should be performed using a cisplatin-based regimen or, if contraindicated, carboplatin.
Rainer Fietkau, Sabine Semrau
openaire   +3 more sources

Chemoradiotherapy

2008
Marcel Verheij, Harry Bartelink
openaire   +1 more source

Chemoradiotherapy in anal cancer

Colorectal Disease, 2011
M Kronfli, Rob Glynne-Jones
openaire   +3 more sources

Combined Chemoradiotherapy Advances

2008
Gordon W. Wong, Minesh P. Mehta
openaire   +3 more sources